e-learning
resources
Virtual 2020
Monday, 07.09.2020
Metabolic alterations and ageing in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2020 - Investigating the effect of Z alpha-1 antitrypsin expression on mitochondrial injury
A. Glasgow (Dublin 9, Ireland)
Source:
Virtual Congress 2020 – Metabolic alterations and ageing in lung disease
Session:
Metabolic alterations and ageing in lung disease
Session type:
Oral Presentation
Number:
3704
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Glasgow (Dublin 9, Ireland). LSC - 2020 - Investigating the effect of Z alpha-1 antitrypsin expression on mitochondrial injury. 3704
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
LSC - 2017 - The serum levels of alpha-1 antitrypsin are strongly associated with its local production by NSCLC tumor cells
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021
Oxidative stress in TGF-β1-mediated fibrosis in Z alpha-1 antitrypsin cells
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vitro
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Intra-epithelial polymerization, accumulation and secretion of alpha
1
antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010
Impact of alpha-1 antitrypsin level on longitudinal lung function change: The Nagahama Study
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019
LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold
Source: Eur Respir J, 59 (2) 2101410; 10.1183/13993003.01410-2021
Year: 2022
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008
Investigation of intracellular stress mechanisms associated with z alpha 1-antitrypsin production
Source: Eur Respir J 2003; 22: Suppl. 45, 80s
Year: 2003
Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
microRNA regulation of the alpha-1 antitrypsin gene
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Alpha-1 antitrypsin: functional analysis of novel variants
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014
Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD)
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005
Inflammation induced conformational changes in Z alpha-1 antirypsin promotes lung Z-AT cell damage
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept